Bayer Statement on Stephens Trial
Bayer today released the following statement on the beginning of the Stephens Trial in the Superior Court of California, County of San Bernardino.
August 5, 2021
Bayer today released the following statement on the beginning of the Stephens Trial in the Superior Court of California, County of San Bernardino.
Leverkusen, July 29, 2021 – Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process.
Bayer today released the following statement on the ruling on its motion for summary judgment in Stephens: “The federal preemption ruling in Stephens is an important decision. It adds to the growing case law holding that a state law-based cancer warning label on glyphosate-based herbicides cannot stand. That is because it would conflict with the […]
Leverkusen, May 27, 2021– Bayer announced today a series of actions it plans to implement following the denial of the motion to preliminarily approve the Roundup™ class settlement agreement.
May 19, 2021 — Bayer today released the following statement on questions raised by Judge Chhabria during a hearing on the class agreement.
Bayer said today that, after careful and extensive consideration, it has decided not to file a petition for certiorari with the U.S. Supreme Court in the case of Dewayne Johnson v Monsanto, which will bring an end to this California state case.
Class counsel, with the company’s support, has asked the Court to extend the schedule for the preliminary approval hearing until May 13
Amicus Letters Filed in California Supreme Court in Support of Monsanto’s Petition for Review of Johnson Case
Monsanto filed a petition with the highest court in California seeking its review of the decision in Dewayne Johnson v. Monsanto Company, the first case in the Roundup™ litigation to go to trial. Monsanto asserts in the petition that the Court of Appeal’s recent decision warrants review because it conflicts with the law and longstanding legal principles with regard to federal preemption, design defect, failure to warn and punitive damages.
Bayer announced that it is in agreement with counsel representing the proposed Roundup settlement class on their decision to withdraw the pending motion for preliminary approval of the parties’ issue class agreement.
Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.
Read about the five-point plan here.